CIDRAP newsletters options
Screenings for breast cancer and cervical cancer fell 6% and 11%, respectively.
Also, an expert weighs in on crafting clear public health messaging that doesn't stigmatize yet doesn't miss key groups.
Over the study period, the proportion who were boosted rose from 49% to 85%.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A study of 4,737 COVID-19 patients in Israel conducted during the Omicron surge concludes that Pfizer's antiviral drug Paxlovid roughly halves the risk of severe COVID-19 or death, according to findings published yesterday in Clinical Infectious Diseases.
Moms' vaccination provided infants 71% protection against Delta and 33% against Omicron.
Also, a study notes potential undetected spread of the disease in Europe at least since early April.
Pfizer and BioNTech submitted an EUA request for their vaccine in kids 6 months to 4 years old.
Compared with reverse-transcription polymerase chain reaction (RT-PCR) testing, dogs can detect COVID-19 infections via scent with high sensitivity (97%)—though lower specificity (91%)—even when patients are asymptomatic, according to a study in PLOS One yesterday.
An analysis of studies published over the past two decades shows that human intestinal carriage of multidrug-resistant (MDR) Escherichia coli has risen substantially in healthcare and community settings around the world, researchers reported today in JAC-Antimicrobial Resistance.
Though falling or holding steady elsewhere, COVID cases are still increasing in the Americas region.
"There may have been undetected transmission for a while," a WHO official says.
Too-high pulse oximetry readings led clinicians to believe patients weren't ill enough for certain therapies.
A new analysis of a randomized clinical trial shows that a repeated post-discharge decolonization regimen for methicillin-resistant Staphylococcus aureus (MRSA) carriers reduced MRSA colonization overall and at multiple body sites, researchers reported yesterday in Clinical Infectious Diseases.
Three COVID-19 vaccine doses offer good protection against infection and hospitalization, including those caused by variants of concern—regardless of brand, type, or combination, according to an ongoing meta-analysis published yesterday in BMJ.
In the US, the more transmissible BA.2.12.1 subvariant now makes up nearly 60% of sequenced samples.
"There's a window of opportunity where this can be contained," a WHO official says.
The findings reveal substantial global collateral damage during the pandemic.
The World Health Assembly (WHA) last week passed a resolution that aims to make infection prevention and control (IPC) a critical element of addressing healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) and of preparing for infectious disease health emergencies.
About 75% of COVID-19 deaths in the least-vaccinated Chicago areas could have been prevented if their uptake would have equaled that of the highest-coverage areas during the Alpha and Delta variant surges, suggests a study late last week in JAMA Network Open.
